Enlivex Therapeutics Ltd. (ENLV)

NASDAQ: ENLV · IEX Real-Time Price · USD

1.322

-0.058 (-4.20%)

At close: Jul 2, 2024, 3:59 PM

1.320

-0.002 (-0.15%)

After-hours: Jul 2, 2024, 7:53 PM EDT

Enlivex Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2014
Market Capitalization	28	50	72	115	87	4	Upgrade
Market Cap Growth	5.12%	-30.73%	-36.72%	31.51%	2372.48%	36.23%	Upgrade
Enterprise Value	4	23	22	30	51	-7	Upgrade
PE Ratio	-	-1.73	-2.33	-7.92	-7.37	-0.37	Upgrade
PB Ratio	1.03	1.67	1.27	1.35	2.46	0.31	Upgrade
P/FCF Ratio	-3.20	-2.13	-2.26	-5.98	-7.24	-0.49	Upgrade
P/OCF Ratio	-3.17	-2.13	-3.03	-6.53	-7.91	-0.50	Upgrade
EV/EBITDA Ratio	-1.84	-0.80	-0.89	-1.62	-4.46	0.73	Upgrade
EV/EBIT Ratio	-1.79	-0.78	-0.86	-1.58	-4.35	0.70	Upgrade
EV/FCF Ratio	-2.14	-0.97	-0.69	-1.59	-4.27	0.91	Upgrade
Debt / Equity Ratio	-	-	-	-	0.03	0.30	Upgrade
Debt / EBITDA Ratio	-	-	-	-	-0.10	-0.38	Upgrade
Debt / FCF Ratio	-	-	-	-	-0.10	-0.47	Upgrade
Quick Ratio	6.49	4.51	7.60	17.83	8.44	2.26	Upgrade
Current Ratio	7.86	5.57	7.92	18.32	8.72	2.75	Upgrade
Interest Coverage	-	-	-4.90	-	-	-	Upgrade
Return on Equity (ROE)	-74.20%	-71.00%	-46.70%	-16.40%	-37.50%	-69.70%	Upgrade
Return on Assets (ROA)	-61.90%	-59.10%	-40.60%	-15.10%	-32.20%	-49.00%	Upgrade
Return on Capital (ROIC)	-99.67%	-97.71%	-45.38%	-22.68%	-26.69%	-58.70%	Upgrade
Earnings Yield	-94.19%	-57.89%	-42.84%	-12.63%	-13.57%	-266.33%	Upgrade
FCF Yield	-79.76%	-47.05%	-44.24%	-16.73%	-13.80%	-205.20%	Upgrade
Buyback Yield / Dilution	-1.14%	-0.98%	-3.00%	-35.62%	-52.25%	-146.47%	Upgrade
Total Shareholder Return	-1.14%	-0.98%	-3.00%	-35.62%	-52.25%	-146.47%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).